Petro E, Perumal-Pillay V, Mantel-Teeuwisse A K, van den Ham H A, Suleman F
Local Healthcare Unit, Durres, Albania.
Utrecht WHO Collaborating Centre for Pharmaceutical Policy and Regulation, Division of Pharmacoepidemiology and Clinical Pharmacology, Utrecht Institute for Pharmaceutical Sciences (UIPS), Utrecht University, Utrecht, the Netherlands.
J Pharm Policy Pract. 2023 Dec 16;17(1):2290100. doi: 10.1080/20523211.2023.2290100. eCollection 2024.
The WHO Essential Medicine List for Children was released on the 30th anniversary of the general Essential Medicine List in 2007, to recognise special needs for medicines in children, and to promote the inclusion of paediatric medicines in national procurement programmes. This study aimed to investigate the alignment of the medicines included in the Albanian reimbursement medicines list of the Mandatory Healthcare Insurance Fund (AMHIF) and the Essential Medicine List for Children.
A quantitative evaluation was performed to compare the paediatric medicines included in the 2022 list of the AMHIF and the 2021 WHO Essential Medicine List for Children. In addition, vaccines in the Albanian vaccination programmes for children were compared to the ones listed on the WHO Essential Medicine List for Children.
Both lists had a total of 284 active ingredients in common, whereas 14 of 24 vaccines were found to be in common in the Essential Medicine List for Children list and the Albanian vaccination programmes.
This is the first study in Albania to investigate the alignment of the WHO EMLc and AMHIF list. In case of the same active ingredient there were many deviations in terms of dosage form, strength and indication.
《世界卫生组织儿童基本药物清单》于2007年在通用基本药物清单发布30周年之际发布，以认识到儿童用药的特殊需求，并促进将儿科药物纳入国家采购计划。本研究旨在调查阿尔巴尼亚强制性医疗保险基金（AMHIF）报销药品清单中的药物与《儿童基本药物清单》的一致性。
进行了定量评估，以比较AMHIF 2022年清单中的儿科药物与2021年《世界卫生组织儿童基本药物清单》。此外，还将阿尔巴尼亚儿童疫苗接种计划中的疫苗与《世界卫生组织儿童基本药物清单》中列出的疫苗进行了比较。
两份清单共有284种活性成分相同，而在《儿童基本药物清单》和阿尔巴尼亚疫苗接种计划中，发现24种疫苗中有14种相同。
这是阿尔巴尼亚第一项调查世界卫生组织儿童基本药物清单与AMHIF清单一致性的研究。在活性成分相同的情况下，剂型、规格和适应症方面存在许多差异。
